Lavaca Capital’s Quest Diagnostics DGX Stock Holding History

Lavaca Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-18	Closed	-$2K	–	157
2019 Q1	$2K	Hold	18	–	–	﹤0.01%	356
2018 Q4	$1K	Buy	+18	New	+$1.69K	﹤0.01%	350

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lavaca Capital's DGX Position: Q2 2019 in Review

Lavaca Capital sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 18 shares — an estimated $2K sold.

Lavaca Capital first reported a position in DGX in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

Lavaca Capital reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
Lavaca Capital sold 18 Quest Diagnostics shares in Q2 2019, an estimated $2K.
Lavaca Capital first reported a position in Quest Diagnostics in Q4 2018 and held it in 2 quarters.
Lavaca Capital's Quest Diagnostics position peaked at $2K in Q1 2019.
654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Lavaca Capital's 13F filing for Q2 2019, filed 29 Jul 2019.